Targeting Monoclonal Antibodies to the Tumor Microenvironment for Cancer Therapy/Immunotherapy

Erlinda Gordon
Frederick L. Hall1, Sant P. Chawla2, Neal S. Chawla2, Erlinda M. Gordon1,2*
Article information